Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation…

Overview of attention for article published in Frontiers in oncology, November 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter: 5 X users

video: 1 YouTube creator

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 2 Mendeley

Summary X YouTube Dimensions citations

So far, Dimensions has found 1 citation of this research output.

1

The most recent citing publication is shown below. View this citation on Dimensions.

Priming with oncolytic adenovirus followed by anti-PD-1 and paclitaxel treatment leads to improved anti-cancer efficacy in the 3D TNBC model

Article in European Journal of Pharmaceutics and Biopharmaceutics (April 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.